Literature DB >> 9175272

Stereoselective syntheses of the O,N-protected subunits of the tunicamycins.

W Karpiesiuk1, A Banaszek.   

Abstract

The synthesis of the title compounds is described, i.e. coupling of the ylide, generated from the iodophosphonium salt of protected N-phthaloyl-D-galactosamine with 2,3-O-isopropylidene D-ribo-aldehyde afforded an undecose in high yield. Hydroboration-oxidation reaction of the olefinic linkage in the undecose led to the desired tunicamine, as the predominant product. After conversion of the latter to a glycosyl acceptor, this was assembled with the fully protected 2-oxyimino-2-deoxy-alpha-D-arabino-hexopyranosyl bromide, leading to a trehalose-type alpha, beta-disaccharide.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175272     DOI: 10.1016/s0008-6215(97)00018-9

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  4 in total

1.  Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor.

Authors:  Katsuhiko Mitachi; David Mingle; Wendy Effah; Antonio Sánchez-Ruiz; Kirk E Hevener; Ramesh Narayanan; William M Clemons; Francisco Sarabia; Michio Kurosu
Journal:  Angew Chem Int Ed Engl       Date:  2022-06-10       Impact factor: 16.823

2.  A Modular Approach to Phosphoglycosyltransferase Inhibitors Inspired by Nucleoside Antibiotics.

Authors:  Marthe T C Walvoort; Vinita Lukose; Barbara Imperiali
Journal:  Chemistry       Date:  2015-12-10       Impact factor: 5.236

Review 3.  Tunicamycin: chemical synthesis and biosynthesis.

Authors:  Kazuki Yamamoto; Satoshi Ichikawa
Journal:  J Antibiot (Tokyo)       Date:  2019-06-25       Impact factor: 2.649

4.  Biosynthesis of the tunicamycin antibiotics proceeds via unique exo-glycal intermediates.

Authors:  Filip J Wyszynski; Seung Seo Lee; Tomoaki Yabe; Hua Wang; Juan Pablo Gomez-Escribano; Mervyn J Bibb; Soo Jae Lee; Gideon J Davies; Benjamin G Davis
Journal:  Nat Chem       Date:  2012-05-20       Impact factor: 24.427

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.